Avantium NV
AEX:AVTX
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.63
3.6776
|
| Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Avantium NV
Avantium NV
Total Liabilities & Equity
Avantium NV
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Avantium NV
AEX:AVTX
|
Total Liabilities & Equity
€270.5m
|
CAGR 3-Years
45%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Wolters Kluwer NV
AEX:WKL
|
Total Liabilities & Equity
€8.9B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Avantium NV
Glance View
Avantium NV engages in the development and commercialization of bio-based plastics and chemicals using advanced catalysis research and development. The company is headquartered in Amsterdam, Noord-Holland and currently employs 213 full-time employees. The company went IPO on 2017-03-15. The firm develops chemical technologies and production processes to convert bio-based feedstock into sustainable products. The firm's business comprises three segments: Catalysis, Renewable Chemistries, and YXY. Catalysis segment provides catalysis R&D services and systems to chemical, refinery and energy companies, utilizing its Flowrence Technology Platform to devise the appropriate catalyst testing solutions. Renewable Chemistries is the development division with a portfolio of projects focusing on the conversion of biomass to chemical building blocks and plastic materials. The YXY segment comprises the activities of Syviana, the joint venture with BASF SE. The YXY technology is used to convert plant-based sugars into chemical building blocks for plastics, such as polymer polyethylenefuranoate (PEF), and other applications.
See Also
What is Avantium NV's Total Liabilities & Equity?
Total Liabilities & Equity
270.5m
EUR
Based on the financial report for Jun 30, 2024, Avantium NV's Total Liabilities & Equity amounts to 270.5m EUR.
What is Avantium NV's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
22%
Over the last year, the Total Liabilities & Equity growth was 41%. The average annual Total Liabilities & Equity growth rates for Avantium NV have been 45% over the past three years , 22% over the past five years .
You don't have any saved screeners yet
